The foundations are solid and the building blocks are starting to take a shape. This income will grow, and further sales to come in Australia when the chronic pain hard-shell capsules are released soon.
I see 2019 as a big year for AC8.
AC8 Price at posting:
70.0¢ Sentiment: Buy Disclosure: Held